Header
 
Search Website
GO
The Cooperative Trials Group for Neuro-Oncology (COGNO) was established in 2007, following identification of a need to develop a central mechanism enabling a coordinated, structured approach to the management of large scale multi-centred neuro-oncology trials.
 
COGNO is a member of the Cooperative Clinical Trials Groups of the Clinical Oncological Society of Australia (COSA) and has a close working relationship with the COSA Neuro-Oncology Group. COGNO is funded by Cancer Australia. The group is located at the National Health and Medical Research Council (NHMRC) Clinical Trials Centre (CTC), at the University of Sydney. The NHMRC CTC coordinates the trials activity within COGNO.
 
COGNO's main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours.
 
 

Donations
 
Are you interested in donating money for COGNO research activities or for other support services? If so, please complete this form and email it back to cogno@ctc.usyd.edu.au
 
If you would prefer to donate online, please visit http://give.sydney.edu.au/COGNO
 
 

BCBA Bike Ride for Brain Cancer Fundraiser: 9-10 March 2018
 
Brain Cancer Biobanking Australia (BCBA) held a 2 day fundraising Bike Ride for Brain Cancer – 250km from Sydney to the Hunter Valley -  on 9 and 10 March 2018. The date coincides with the birthday of Lucie Leonard, who died from brain cancer in 2012, and is the inspiration for the establishment of BCBA. For further information visit https://www.bikerideforbraincancer.com.au/about-the-event
 
 

Ideas or Concepts

COGNO is interested in developing new concepts into protocols and translating these into clinical research.

If you have a concept you are interested in developing, please complete this online form.

Recent News

8/08/2018: COGNO ASM Travel Grant for Neuro-Oncology Nurse/Care Coordinator
 

COGNO is pleased to announce that applications are open for a travel grant to attend the 2018 COGNO Annual Scientific Meeting (ASM). The travel grant is valued at up to $1,500 and is to be used for expenses incurred in attending the Annual Scientific Meeting by a neuro-oncology nurse/care coordinator.

 more...
1/08/2018: COGNO: Comment by 14 August 2018 - MRFF Priorities Consultation Discussion Paper
 

The Australian Medical Research Advisory Board (AMRAB) is conducting a national consultation to inform the development of the second set of Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities (Priorities) for 2018-2020. This is an opportunity to help shape the MRFF Priorities for 2018-2020 and ensure these Priorities accurately reflect strategic research investment opportunities. COGNO will be making a submission and invites your input on the following questions (bullet points are fine) by cob Tuesday 14 August 2018 to cogno@ctc.usyd.edu.au:

 more...
1/08/2018: COGNO ASM Session 5: Glioma Including Plenary 4
 

Day two of COGNO ASM 2018 will kick off with neuro-oncology?s greatest challenge: Gliomas. The era of precision medicine raises many questions: how do we make sense of the myriad of molecular markers now available; how do we use this information to target treatments; and how do we assess response? In this session, local and international experts will address some of these challenges and update us on exciting developments in the field.

 more...